Belgium’s deputy prime minister has called on the EU to deploy its Anti-Coercion Instrument against Washington’s most-favored-nation drug pricing policy, as eight member states weigh a joint pharmaceutical task force.
Belgium’s deputy prime minister has called on the EU to deploy its Anti-Coercion Instrument against Washington’s most-favored-nation drug pricing policy, as eight member states weigh a joint pharmaceutical task force.
Resolution 002445 of October 22, 2026 opens a direct credit facility through the Administradora de los Recursos del Sistema General de Seguridad Social en Salud (ADRES), with disbursements going straight …
Resolution 1447/2026 replaces the 2021 primary-care essential medicines list behind Argentina’s Remediar programme with a list focused on vascular disease, leaving other conditions to provincial procurement after a transition kit …
A Mexican health-systems researcher warns that the new scheme could generate more demand than the social-security institutions can absorb, and that far more public investment is indispensable, though not sufficient, …
On October 14, 2026, the FDA announced the Rare Disease Framework Initiative to develop a fit-for-purpose framework for rare disease drug development, led by its Rare Disease Innovation Hub, with …
A study led by Rare Diseases International finds rare disease patients in Colombia wait an average of 25 months for a diagnosis, and up to 19 years in some cases.
Brazil’s federal health ministry began dispensing nine new cancer drugs through the public Sistema Único de Saúde (SUS) network this week, for more than 116,000 patients, and expects all 23 …
Mexico’s public mental health system is severely under-resourced even as nearly five million people in Mexico live with a mental health condition. The Instituto Mexicano del Seguro Social (IMSS) fields …
Brazil’s public health system (SUS) has added extended-release lithium on tolerability and adherence grounds, and the Dominican health-insurance regulator, the Superintendency of Health and Occupational Risks (SISALRIL), is studying wider …
Colombia’s Consejo de Estado has upheld an order requiring the government to lay the foundations of a new national pharmaceutical policy, with potential consequences for drug pricing, supply, and local …
You must be logged in to post a comment.